Nature Publishing Group, publisher of Nature, and other science journals and reference works NATURE.COM NATURE NEWS NATUREJOBS NATUREEVENTS ABOUT NPG
Help Nature.com site index  
European Journal of Human Genetics
SEARCH     advanced search my account e-alerts subscribe register
Journal home
Advance online publication
Current issue
Archive
Press releases
For authors
For referees
Contact editorial office
About the journal
About the society
For librarians
Subscribe
Advertising
naturereprints
Contact NPG
Customer services
Site features
NPG Subject areas
Access material from all our publications in your subject area:
Biotechnology Biotechnology
Cancer Cancer
Chemistry Chemistry
Dentistry Dentistry
Development Development
Drug Discovery Drug Discovery
Earth Sciences Earth Sciences
Evolution & Ecology Evolution & Ecology
Genetics Genetics
Immunology Immunology
Materials Materials Science
Medical Research Medical Research
Microbiology Microbiology
Molecular Cell Biology Molecular Cell Biology
Neuroscience Neuroscience
Pharmacology Pharmacology
Physics Physics
Browse all publications
 
August 2000, Volume 8, Number 8, Pages 649-651
Table of contents    Previous  Abstract  Next   Article  PDF
Short Report
Identification of genetic heterogeneity in Refsum's disease
Anthony S Wierzbicki1,2, John Mitchell3, Michelle Lambert-Hammill1, Margaret Hancock2, Juliet Greenwood3, Margaret C Sidey4, Jacqueline de Belleroche3 and F Brian Gibberd4

1Department of Chemical Pathology, King's Guy's & St Thomas' Medical School, King' College, London, UK

2Department of Chemical Pathology, Imperial College of Science, Technology and Medicine, Chelsea & Westminster Hospital, London, UK

3Department of Neuromuscular Disease, Imperial College of Science, Technology and Medicine, Charing Cross Hospital, London, UK

4Department of Clinical Pharmacology and Therapeutics, Imperial College of Science, Technology and Medicine, Chelsea & Westminster Hospital, London, UK

Correspondence to: DrA S Wierzbicki , Department of Chemical Pathology, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, UK. Tel: +44 20 7 928 9292 x 2027; Fax: +44 20 7 928 4226; E-mail: Anthony.Wierzbicki@kcl.ac.uk

Abstract

Refsum's disease (MIM 266500) is a recessive disorder characterised by defective peroxisomal alpha-oxidation of phytanic acid. A Refsum's disease gene, phytanoyl-CoA hydroxylase (PAHX), has been localised to chromosome 10p13 between the markers D10S226-D10S223. This study investigated whether all cases of Refsum's disease were linked with chromosome 10p13. Eight genetically informative families comprising 92 individuals including 17 living patients with a Refsum's disease phenotype and initial plasma phytanic acid >200 mumol/L were recruited. Linkage to the 10pter-10p11.2 region was investigated using a panel of eight dinucleotide repeat markers. Linkage analysis of this phenotypically identical cohort suggested that Refsum's disease was genetically heterogeneous (Zmax = 5.28, alpha = 0.45). Two subgroups were identified. One group of four families with eight affected individuals had a maximum multipoint lod score for linkage of 3.89 in the region D10S547 to D10S191, whilst in another three families with nine affected individuals linkage to this region was definitely excluded. Our results show that Refsum's disease is genetically heterogeneous, with up to 55% of cases not being linked to the PAHX gene locus at D10S547 to D10S223. This suggests that Refsum's disease, in common with other peroxisomal 'diseases', may be more accurately described as a heterogeneous syndrome. European Journal of Human Genetics (2000) 8, 649-651.

Keywords

Refsum's disease; phytanic acid; linkage; heterogeneity

Received 5 July 1999; revised 6 April 2000; accepted 27 April 2000
August 2000, Volume 8, Number 8, Pages 649-651
Table of contents    Previous  Abstract  Next   Article  PDF
Privacy Policy © 2000 Nature Publishing Group